loff ARARE _ 130 March 31, 2003 Regular Mail `The Honorable Stephen L.
refid# By8JGe2jNxJXMJG9bgJpV6ynw10 pages
re ar +1. 5L PonT pre bE NEmoURS & Company nies PanxePn.sOs.uBnoeWx,.12V1a7. 28102 AR226 _ 133] co: HTaizmaortdhoyusT.WeLsatrea/wGaryound Water Branch WY Division of Water Resources C1h2a01rleGsrteoenn,briWeWr 2S5t3r1e1et CERTIFIED MAIL - RETURN RECEIPT REQUESTED MHra.zaSrtdoeupshenWasR.te WMaasnsaegresumge,nt DiDrievcitsoiron USS.
refid# vVpjo6dzLeRON56myK5egK92E3 pages
AR &86- 1351 Page 1 EpidFemIiNoAloLgyR,E2P2O0-R3TW-05 Medical Department 3M Company St.
refid# 0Lbjov5xjEYDj0LpXn8jVd55V41 pages
ARA26 -- 147] + ' PERSONAL AND CONFIDENTIAL E 0: RC..
refid# O3ekYKa9eaGbmxNw2B2yK7Gk124 pages
S.L Internal Correspondence [Feaegscor=s=e| ARE-0466> I| % D.
refid# EvqV1GbLrnVojmVbv3kQa1NQ02 pages
: 3M MEDICAL DEPARTMENT TOXICOLOGY SERVICES To: Georjean Adams 290-4-01 cc: John Butenhoff 220-2E-02 From: Marv Case 220-2E-02 Subject: FC 95 and 143 Teratology Date: 26 May 1998 John passed on to me your request for someone to review and write an analysis on the eye lens defect that was reported in the the toxicology study files on FC 95 original and FC FC 143. 95 rat teratology study.
refid# npxvwqq58bzmRML5pRM8VjowX3 pages
AR126-0 595 ACTIVATED SLUDGE RESPIRATION INHIBITION I TESTE SUBSS TANT CE ~S ~U ~ BSTANGE Identity: PPeFrOflAuoarmoomcotnaniouimc ascailtd,, Aammmmoonniiuumm psaelrtf;lmuoaryooacltsaonobaeter,efPeFrrOe,d FtoC-as. +11a6m,mFoCn-i1u26m,sFalCt-,1C6A9,So#r3F8C2-51-4236.-1()Octanoic acid, pentadecafiuoro- R14e3m.arIkt'ss :puritTyhweas3Mnoptrsoudfufcitciieonntllyotchnaurmabcteerriwzaeds,3t7h.ouTghhectuersrtesntamipnlfoermisatFiCo-n ainnddiCcastpeesriftliusoaromiaxntaulroegoufe9c6o.5mp-o1u0n0d%s.test substance and 0 -- 3.5% Ce, Cr, wMEETTWHOODD: Methods: Protocol Reference EAR, 11/8/79.
refid# NEnDVyxoe40YZgoRxegwx9kMp4 pages
AR226-0516 Testsuestawce ACUTE TOXICITY TO FISH TEST SUBSTANCE Identity: Perfluorooctanoic acid, ammonium salt; may also be referred to as PFOA ammonium salt, Ammonium perfluorooctanoate, PFO, FC-116, FC-126, FC-168, FC-143, or as a major component of FX-1003.
refid# 0ygyLd8dno68733mMxO4o1Gb25 pages
Lo. ." se am Lam KABA tt ert StaffaVicere, SEHR President __ 0399_ - 373 ee nARE-S0842 s A POBoxiN 3320n n.m Lo 9pose cb2 pay 19 27gedTR ay%q \, 0 Mr.
refid# 6wdErKEBXK40YZnDmm0bQ2ov35 pages
co 17r EEE as16 O10 AR 226 _ 06/9 2 Phasing Out a Problem: Perfluorooctyl Sulfonate (PFOS) Mary F.
refid# 33zMBeYnEYBo3nXe202J5zMa17 pages
aE AR226 -- 063] Dainippon Ink & Chemicals, Inc.
refid# omXQBnypk11DB632DjDMnb4w32 pages
AR R26 -- 0752 ACTIVATED SLUDGE RESPIRATION INHIBITION TEST TEST SUBSTANCE Identity: ArefmeirxrteudretocaonstaPiFnOiSng, pFeCr-f9i5u,oroorocatsanaescuolfmopnaotne,ewnohtficFhC-m2a0y3CaEl.so b(1eOctanesulfonic acid) (CAS # 2795-39-3).
refid# mp8LJGpg47p8rMLeaK8G2ommk9 pages
.
refid# MMJ5YNEN3bw9y1N2DabOxOa5y3 pages
a .i TpaIED E. 1.
refid# k66e10J77anej4EyebXgkyRmD4 pages
~AR226-/7/6 CANCER PREVALENCE IN SUBJECTS EXPOSED TO PERFLUOROOCTANONIC ACID (PFOA) Jam ors es Dahlgren MD', Ayman B enero Torabim MD'*', Raphael Warshaw', seston Harpreet Takbar MPH' i.
refid# oQr0ZQmR5gd66BVRqnMRVy681 page